Small cell lung cancer Trials in Barcelona, Spain
Conditions / Small cell lung cancer / Barcelona, Spain
Small cell lung cancer has been the subject of sustained clinical investigation across multiple research sites.
46 total trials for this combination
Showing top 10 of 46 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06117774 | Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) | ACTIVE_NOT_RECRUITING | — |
| NCT03219268 | A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms | COMPLETED | PHASE1 |
| NCT05983432 | Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors | RECRUITING | PHASE1 |
| NCT05620134 | Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT06117774 | Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) | ACTIVE_NOT_RECRUITING | — |
| NCT06117774 | Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) | ACTIVE_NOT_RECRUITING | — |
| NCT04802876 | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04585750 | The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) | RECRUITING | PHASE1/PHASE2 |
| NCT04234113 | Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors | TERMINATED | PHASE1 |
| NCT06117774 | Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) | ACTIVE_NOT_RECRUITING | — |